Büssing A, Regnery A, Schweizer K
Institute of Medical Immunology, Technical University (RWTH) Aachen, Germany.
Cancer Lett. 1995 Aug 1;94(2):199-205. doi: 10.1016/0304-3835(95)03850-v.
Based on recently published data, Viscum album L. (VAL) extracts have been shown to provide a DNA stabilizing effect which seems to be restricted to the peripheral blood mononuclear cells (PBMC). We have now investigated whether VAL exerts effects of cellular protection for phytohemagglutinin-activated PBMC treated with cyclophosphamdie (CP) in vitro. The addition of VAL resulted in a slight reduction of CP-induced sister chromatid exchanges of cultured PBMC from healthy individuals. The incubation with CP significantly reduced the expression of the low affinity interleukin-2 receptor (IL-2R alpha chain) and of transferrin receptor (TfR) on PHA-stimulated T lymphocytes. The addition of 10 micrograms/ml VAL was protective against the CP-induced depression of IL-2R alpha chain and TfR expression on these cells. The simultaneous addition of CP and purified VAL components, such as ML I, ML II/III, and viscotoxins did not significantly change expression of IL-2R alpha chain and TfR on T cells. Thus, so far undefined VAL components might be responsible for the observed protection effects of the whole plant extract. The results presented here should encourage investigation of this drug, which might become an interesting adjuvant in cancer therapy.
基于最近发表的数据,欧洲槲寄生提取物已被证明具有DNA稳定作用,这种作用似乎仅限于外周血单核细胞(PBMC)。我们现在研究了欧洲槲寄生是否对体外经环磷酰胺(CP)处理的植物血凝素激活的PBMC具有细胞保护作用。添加欧洲槲寄生导致健康个体培养的PBMC中CP诱导的姐妹染色单体交换略有减少。CP孵育显著降低了PHA刺激的T淋巴细胞上低亲和力白细胞介素-2受体(IL-2Rα链)和转铁蛋白受体(TfR)的表达。添加10微克/毫升欧洲槲寄生可防止CP诱导这些细胞上IL-2Rα链和TfR表达的降低。同时添加CP和纯化的欧洲槲寄生成分,如ML I、ML II/III和槲寄生毒素,并未显著改变T细胞上IL-2Rα链和TfR的表达。因此,迄今为止尚未明确的欧洲槲寄生成分可能是该植物提取物观察到的保护作用的原因。这里给出的结果应该会鼓励对这种药物进行研究,它可能会成为癌症治疗中一种有趣的辅助药物。